Showing results (271-280 of 353) with videos related to
Sort By:
Pageof 36
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
A retrospective analysis of the relationship between changes in serum PSA, palliative response and survival following systemic treatment in a Canadian randomized trial for symptomatic hormone-refractory prostate cancerA J Dowling, T Panzarella, D S Ernst, et al.Cellular and Molecular Life Sciences : CMLS|April 6, 2001
Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometryA A Alaiya, M Oppermann, J Langridge, et al.Annals of Vascular Surgery|January 11, 1992
The role of intravenous fluorescein in the detection of colon ischemia during aortic reconstructionR T Bergman, P Gloviczki, T J Welch, et al.Heart (British Cardiac Society)|June 2, 2007
The obstacles to maximising the impact of public access defibrillation: an assessment of the dispatch mechanism for out-of-hospital cardiac arrestK J Cairns, A J Hamilton, A H Marshall, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinomaL L Siu, D Banerjee, R J Khurana, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials GroupM J Moore, E W Winquist, N Murray, et al.Biochemistry|March 20, 1990
Use of a site-directed triple mutant to trap intermediates: demonstration that the flavin C(4a)-thiol adduct and reduced flavin are kinetically competent intermediates in mercuric ion reductaseS M Miller, V Massey, D Ballou, et al.European Journal of Biochemistry|October 15, 1996
Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18L Rydlander, E Ziegler, T Bergman, et al.Biochemistry|February 7, 1989
Evidence for the participation of Cys558 and Cys559 at the active site of mercuric reductaseS M Miller, M J Moore, V Massey, et al.Nanomedicine (London, England)|June 25, 2015
Oxime ether lipids containing hydroxylated head groups are more superior siRNA delivery agents than their nonhydroxylated counterpartsKshitij Gupta, Stephanie J Mattingly, Ralph J Knipp, et al.Pageof 36